(Q52930964)

9 May 2018

title

Assessment of a dose-response relationship of levetiracetam. (English)

1 reference

9 May 2018

author name string

H-J Meencke

series ordinal

1

1 reference

9 May 2018

S Buyle

series ordinal

2

1 reference

9 May 2018

publication date

1 September 2006

1 reference

9 May 2018

European Journal of Neurology

published in

1 reference

9 May 2018

volume

13

1 reference

9 May 2018

issue

9

1 reference

9 May 2018

page(s)

942-946

1 reference

9 May 2018

Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01381.X

The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01381.X

Revisiting the concept of identifiable neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01381.X

Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01381.X

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01381.X

Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01381.X

Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01381.X

Safety profile of levetiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01381.X

A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01381.X

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01381.X

10.1111/J.1468-1331.2006.01381.X

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018